The real-world effectiveness of sucroferric oxyhydroxide in European hemodialysis patients: a 1-year retrospective database analysis

The real-world effectiveness of sucroferric oxyhydroxide in European hemodialysis patients: a 1-year retrospective database analysis

Abstract Background The iron-based phosphate binder (PB), sucroferric oxyhydroxide (SFOH), demonstrated its effectiveness for lowering serum phosphate levels, with low daily pill burden, in clinical trials of dialysis patients with hyperphosphatemia. This retrospective database analysis evaluated th...

Full description

Bibliographic Details
Main Authors: Rosa Ramos, Charles Chazot, Anibal Ferreira, Attilio Di Benedetto, Konstantin Gurevich, Astrid Feuersenger, Melanie Wolf, Hans-Jürgen Arens, Sebastian Walpen, Stefano Stuard
Format: Article
Language:English
Published: BMC 2020-12-01
Series:BMC Nephrology
Subjects:
Chronic kidney disease
End-stage renal disease
Hemodialysis
Hyperphosphatemia
Phosphate binder
Sucroferric oxyhydroxide
Online Access:https://doi.org/10.1186/s12882-020-02188-8

Internet

https://doi.org/10.1186/s12882-020-02188-8

Similar Items